Identification of key residues involved in the neuraminidase antigenic variation of H9N2 influenza virus
- PMID: 33467981
- PMCID: PMC7872579
- DOI: 10.1080/22221751.2021.1879602
Identification of key residues involved in the neuraminidase antigenic variation of H9N2 influenza virus
Abstract
Influenza A H9N2 virus causes economic loss to the poultry industry and has likely contributed to the genesis of H5N1 and H7N9 viruses. The neuraminidase (NA) of H9N2 virus, like haemagglutinin, is under antibody selective pressure and may undergo antigenic change; however, its antigenic structure remains to be elucidated. In this study, we used monoclonal antibodies (mAbs) to probe the H9N2 viral NA residues that are key for antibody binding/inhibition. These mAbs fell into three groups based on their binding/inhibition of the NA of H9N2 viruses isolated during 1999-2019: group I only bounded the NA of the early 2000 H9N2 viruses but possessed no neutralizing ability, group II bounded and inhibited the NA of H9N2 viruses isolated before 2012, and group III reacted with most or all tested H9N2 viruses. We showed that NA residue 356 is key for the recognition by group I mAbs, residues 344, 368, 369, and 400 are key for the binding/inhibition of NA by group II antibodies, whereas residues 248, 253, and the 125/296 combination are key for neutralizing antibodies in group III. Our findings highlighted NA antigenic change of the circulating H9N2 viruses, and provided data for a more complete picture of the antigenic structure of H9N2 viral NA.
Keywords: H9N2; Influenza virus; antigenic change; key residues; monoclonal antibodies; neuraminidase.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Figures





Similar articles
-
Identification of Hemagglutinin Mutations Caused by Neuraminidase Antibody Pressure.Microbiol Spectr. 2021 Dec 22;9(3):e0143921. doi: 10.1128/spectrum.01439-21. Epub 2021 Dec 22. Microbiol Spectr. 2021. PMID: 34937172 Free PMC article.
-
Comparison of the Efficacy of N9 Neuraminidase-Specific Monoclonal Antibodies against Influenza A(H7N9) Virus Infection.J Virol. 2018 Jan 30;92(4):e01588-17. doi: 10.1128/JVI.01588-17. Print 2018 Feb 15. J Virol. 2018. PMID: 29167344 Free PMC article.
-
Identification of amino acids in H9N2 influenza virus neuraminidase that are critical for the binding of two mouse monoclonal antibodies.Vet Microbiol. 2016 May 1;187:58-63. doi: 10.1016/j.vetmic.2016.03.011. Epub 2016 Mar 16. Vet Microbiol. 2016. PMID: 27066709
-
Genetic and biological characterization of H9N2 avian influenza viruses isolated in China from 2011 to 2014.PLoS One. 2018 Jul 3;13(7):e0199260. doi: 10.1371/journal.pone.0199260. eCollection 2018. PLoS One. 2018. PMID: 29969454 Free PMC article.
-
Evolutionary trajectories and diagnostic challenges of potentially zoonotic avian influenza viruses H5N1 and H9N2 co-circulating in Egypt.Infect Genet Evol. 2015 Aug;34:278-91. doi: 10.1016/j.meegid.2015.06.004. Epub 2015 Jun 3. Infect Genet Evol. 2015. PMID: 26049044
Cited by
-
Recombinant Turkey Herpesvirus Expressing H9N2 HA Gene at the HVT005/006 Site Induces Better Protection Than That at the HVT029/031 Site.Viruses. 2022 Nov 11;14(11):2495. doi: 10.3390/v14112495. Viruses. 2022. PMID: 36423104 Free PMC article.
-
Genetic evolution and molecular characteristics of avian influenza viruses in Jining from 2018 to 2023.Front Microbiol. 2025 Mar 27;16:1551617. doi: 10.3389/fmicb.2025.1551617. eCollection 2025. Front Microbiol. 2025. PMID: 40212390 Free PMC article.
-
A Cross-Reactive Monoclonal Antibody Against Neuraminidases of Both H9N2 and H3N2 Influenza Viruses Shows Protection in Mice Challenging Models.Front Microbiol. 2021 Sep 27;12:730449. doi: 10.3389/fmicb.2021.730449. eCollection 2021. Front Microbiol. 2021. PMID: 34646249 Free PMC article.
-
Engineering an Optimal Y280-Lineage H9N2 Vaccine Strain by Tuning PB2 Activity.Int J Mol Sci. 2023 May 16;24(10):8840. doi: 10.3390/ijms24108840. Int J Mol Sci. 2023. PMID: 37240186 Free PMC article.
-
Characterization of Neutralizing Monoclonal Antibodies and Identification of a Novel Conserved C-Terminal Linear Epitope on the Hemagglutinin Protein of the H9N2 Avian Influenza Virus.Viruses. 2022 Nov 15;14(11):2530. doi: 10.3390/v14112530. Viruses. 2022. PMID: 36423139 Free PMC article.
References
-
- Peiris M, Yuen KY, Leung CW, et al. . Human infection with influenza H9N2. Lancet. 1999;354(9182):916–917. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources